[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

KR100362294B1 - β-락타마제억제제로서의2-β-알케닐페남유도체및약제학적으로허용되는이의염,이의제조방법,및이를함유하는약제 - Google Patents

β-락타마제억제제로서의2-β-알케닐페남유도체및약제학적으로허용되는이의염,이의제조방법,및이를함유하는약제 Download PDF

Info

Publication number
KR100362294B1
KR100362294B1 KR1019940020869A KR19940020869A KR100362294B1 KR 100362294 B1 KR100362294 B1 KR 100362294B1 KR 1019940020869 A KR1019940020869 A KR 1019940020869A KR 19940020869 A KR19940020869 A KR 19940020869A KR 100362294 B1 KR100362294 B1 KR 100362294B1
Authority
KR
South Korea
Prior art keywords
methyl
thia
aza
carboxylate
bicyclo
Prior art date
Application number
KR1019940020869A
Other languages
English (en)
Korean (ko)
Other versions
KR950005830A (ko
Inventor
크리스티앙윔슈베를랑
한스리히터
쟝-뤽스페클렝
Original Assignee
바실리어 파마슈티카 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바실리어 파마슈티카 아게 filed Critical 바실리어 파마슈티카 아게
Publication of KR950005830A publication Critical patent/KR950005830A/ko
Application granted granted Critical
Publication of KR100362294B1 publication Critical patent/KR100362294B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/86—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
KR1019940020869A 1993-08-24 1994-08-24 β-락타마제억제제로서의2-β-알케닐페남유도체및약제학적으로허용되는이의염,이의제조방법,및이를함유하는약제 KR100362294B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH251193 1993-08-24
CH02511/93-8 1993-08-24
CH01687/94-2 1994-05-31
CH01687/94-3 1994-05-31
CH168794 1994-05-31

Publications (2)

Publication Number Publication Date
KR950005830A KR950005830A (ko) 1995-03-20
KR100362294B1 true KR100362294B1 (ko) 2005-08-25

Family

ID=25688383

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940020869A KR100362294B1 (ko) 1993-08-24 1994-08-24 β-락타마제억제제로서의2-β-알케닐페남유도체및약제학적으로허용되는이의염,이의제조방법,및이를함유하는약제

Country Status (22)

Country Link
US (2) US5637579A (fi)
EP (1) EP0640607B1 (fi)
JP (1) JP2642314B2 (fi)
KR (1) KR100362294B1 (fi)
CN (1) CN1067078C (fi)
AT (1) ATE148705T1 (fi)
AU (1) AU674768B2 (fi)
CA (1) CA2129564C (fi)
CZ (1) CZ203994A3 (fi)
DE (1) DE59401750D1 (fi)
DK (1) DK0640607T3 (fi)
ES (1) ES2097589T3 (fi)
FI (1) FI113775B (fi)
GR (1) GR3023228T3 (fi)
HU (1) HUT67880A (fi)
IL (1) IL110711A (fi)
NO (1) NO307054B1 (fi)
NZ (1) NZ264272A (fi)
RU (1) RU2139290C1 (fi)
SG (1) SG48064A1 (fi)
TW (1) TW383308B (fi)
UA (1) UA29435C2 (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686441A (en) * 1995-08-04 1997-11-11 Syphar Laboratories, Inc. Penam sulfones as β-lactamase inhibitors
US6150350A (en) * 1997-09-15 2000-11-21 Hoffman-La Roche Inc. Antimicrobial compositions
JP3866298B2 (ja) 1997-12-29 2007-01-10 リサーチ コーポレイション テクノロジーズ，インコーポレイティド β−ラクタマーゼインヒビターとしての２β−置換化−６−アルキリデンペニシラン酸誘導体
AU6133599A (en) * 1998-09-01 2000-03-21 Merck & Co., Inc. Carbapenem antibacterial compositions and methods of treatment
SK10142001A3 (sk) * 1999-01-26 2002-07-02 American Cyanamid Company 3,6-Disubstituované penamsulfónové deriváty ako antimikrobiálne prípravky
US6395726B1 (en) 1999-01-26 2002-05-28 American Cyanamid Company 3,6-disubstituted penam sulfone derivatives
US6407091B1 (en) 1999-04-15 2002-06-18 Research Corporation Technologies, Inc. β-lactamase inhibiting compounds
US6221859B1 (en) 1999-08-27 2001-04-24 Merck & Co., Inc. Carbapenem antibacterial compositions and methods of the treatment
AU2001292732A1 (en) * 2000-09-12 2002-03-26 Larry C. Blasczcak Beta-lactam analogs and uses therefor
CA2425603C (en) * 2000-10-11 2011-05-24 Healthtrio, Inc. System for communication of health care data
US6916801B2 (en) 2001-07-24 2005-07-12 Alamx, Llc 7-Alkylidene-3-substituted-3-cephem-4-carboxylates as β-lactamase inhibitors
US7022691B2 (en) 2002-04-04 2006-04-04 John D. Buynak Inhibitors of serine and metallo-β-lactamases
DK1965798T3 (da) * 2005-12-07 2011-11-28 Basilea Pharmaceutica Ag Nyttige monobactam-antibiotika
AU2012233003B2 (en) * 2005-12-07 2014-12-18 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
WO2018015280A1 (en) 2016-07-21 2018-01-25 Unilever Plc 4-(4-chlorophenyl)-5-methylene-pyrrol-2-one and 5-methylene-4-(p-tolyl)pyrrol-2-one for use in the treatment of gram negative bacterial infections
EP3487494A1 (en) 2016-07-21 2019-05-29 Unilever PLC Lactams for the treatment of respiratory tract infections
EP3487495A1 (en) 2016-07-21 2019-05-29 Unilever PLC Lactams for use in the treatment of skin lesions
US20200230114A1 (en) * 2019-01-22 2020-07-23 Board Of Regents Of The Nevada System Of Higher Education On Behalf Of Nevada The use of lipophilic beta-lactam antibiotics and carboxylate esters for the treatment of bacterial infections within citrus and other plant species

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331677A (en) * 1978-11-24 1982-05-25 Farmitalia Carlo Erba S.P.A. 7-Oxo-4-1-aza-bicyclo-[3,2,0]-heptane derivatives
US4282236A (en) * 1979-11-07 1981-08-04 Beecham Group Limited β-Lactam antibacterial agents, their use in pharmaceutical compositions, and intermediates
US4365174A (en) * 1980-07-31 1982-12-21 Rca Corporation Pulse counter type circuit for power-up indication
ZA826687B (en) * 1981-09-14 1983-07-27 Pfizer Beta-lactamase inhibiting 2-beta-substituted-2-alpha-methyl 5(r)penam-3-alpha-carboxylic acid 1,1-dioxides and intermediates therefor
GB8509180D0 (en) * 1985-04-10 1985-05-15 Erba Farmitalia Penem derivatives
US4861768A (en) * 1986-02-27 1989-08-29 Taiho Pharmaceutical Company, Limited 2 β-substituted thiomethylpenicillin derivatives and their preparation and use
US4891369A (en) * 1986-12-03 1990-01-02 Taiho Pharmaceutical Company, Limited 2β-Substituted-methylpenicillanic acid derivatives, and salts and esters thereof
US5132300A (en) * 1989-06-01 1992-07-21 Pfizer Inc. Beta-lactam elastase inhibitors

Also Published As

Publication number Publication date
JPH0782273A (ja) 1995-03-28
FI943885A (fi) 1995-02-25
TW383308B (en) 2000-03-01
NZ264272A (en) 1996-10-28
JP2642314B2 (ja) 1997-08-20
NO943104D0 (no) 1994-08-23
HU9402391D0 (en) 1994-10-28
ES2097589T3 (es) 1997-04-01
CA2129564C (en) 2006-07-25
FI943885A0 (fi) 1994-08-24
IL110711A0 (en) 1994-11-11
CA2129564A1 (en) 1995-02-25
HUT67880A (en) 1995-05-29
NO307054B1 (no) 2000-01-31
RU2139290C1 (ru) 1999-10-10
US5637579A (en) 1997-06-10
UA29435C2 (uk) 2000-11-15
CN1067078C (zh) 2001-06-13
DE59401750D1 (de) 1997-03-20
AU7035694A (en) 1995-03-09
SG48064A1 (en) 1998-04-17
ATE148705T1 (de) 1997-02-15
NO943104L (no) 1995-02-27
CZ203994A3 (en) 1995-03-15
RU94030236A (ru) 1996-06-20
EP0640607B1 (de) 1997-02-05
EP0640607A1 (de) 1995-03-01
FI113775B (fi) 2004-06-15
DK0640607T3 (da) 1997-06-16
KR950005830A (ko) 1995-03-20
AU674768B2 (en) 1997-01-09
GR3023228T3 (en) 1997-07-30
CN1106408A (zh) 1995-08-09
IL110711A (en) 1999-08-17
US5644053A (en) 1997-07-01

Similar Documents

Publication Publication Date Title
KR100362294B1 (ko) β-락타마제억제제로서의2-β-알케닐페남유도체및약제학적으로허용되는이의염,이의제조방법,및이를함유하는약제
RU2143435C1 (ru) β-ЛАКТАМЫ
US5510343A (en) Bicyclic and tricyclic β-lactams
CA1339450C (en) Stable oxapenem-3-carboxylic acids
SU1192626A3 (ru) Способ получени 1,1-диоксида пенициллановой кислоты или ее эфира
US5108747A (en) Stable oxpenem-3-carboxylic acids as beta-lactamase inhibitors
US5686441A (en) Penam sulfones as β-lactamase inhibitors
US4426377A (en) Clavulanic acid derivatives their preparation and use
US4444754A (en) Derivatives of clavulanic acid, a process for their preparation and their use
US4762921A (en) 6-(1-acyl-1-hydroxymethyl)penicillanic acid derivatives
EP0201221B1 (en) 6-(1-acyl-1-hydroxy methyl) penicillanic acid derivatives
US4426389A (en) Derivatives of clavulanic acid, a process for their preparation and their use
US4427678A (en) 6-Aminomethylpenicillanic acid 1,1-dioxide derivatives as beta-lactamase inhibitors
US5712268A (en) Compositions of tricyclic β-lactams and uses thereof
EP0112685B1 (en) Compounds containing beta-lactams
US4343807A (en) Derivatives of clavulanic acid, a process for their preparation and their use
US4409207A (en) Derivatives of clavulanic acid, a process for their preparation and their use
EP0421751A2 (en) Substituted acrylamido-penicillanic acid esters

Legal Events

Date Code Title Description
A201 Request for examination
N231 Notification of change of applicant
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20091110

Year of fee payment: 8

LAPS Lapse due to unpaid annual fee